Atlas Trials

IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)

Clinical trial NCT04575610 · TERMINATED

Trial details

NCT number
NCT04575610
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-11-27
Primary completion
2021-10-06
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.